Biotech Values

[DewDiligence]

Today’s NYT article on Pradaxa is a textbook case of bias stemming from asymmetric information:

http://www.nytimes.com/2012/11/03/business/a-rising-anti-stroke-drug-is-tied-to-risk-of-bleeding-deaths.html

What I mean by asymmetric information is that, when people bleed to death on Pradaxa, everyone “knows” the drug is at fault because there is no antidote; however, when patients die while on warfarin, the cause is less obvious and the drug doesn’t automatically get blamed.